{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:41Z","timestamp":1792785041829,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Higher Education","award":["PRIHATIN-2021-001"],"award-info":[{"award-number":["PRIHATIN-2021-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51737-y","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:42:20Z","timestamp":1778240540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Amplifying immune responses via a parenteral prime-intranasal boost strategy using a lipidated chitosan nanoparticle-based multi-epitope COVID-19 vaccine"],"prefix":"10.1038","volume":"16","author":[{"given":"Chai Jian","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Al-Hadi Ahmad","family":"Fuaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Azila Muhammad","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Nur Zawani","family":"Rosli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Fei","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Cairul Iqbal Mohd","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazren","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"2","key":"51737_CR1","doi-asserted-by":"publisher","first-page":"e00133","DOI":"10.1128\/CMR.00133-20","volume":"34","author":"A Synowiec","year":"2021","unstructured":"Synowiec, A., Szczepa, A., Barreto-Duran, E., Lie, L. K. & Pyrc, K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A systemic infection. Clin. Microbiol. Rev. 34 (2), e00133\u2013e00120. https:\/\/doi.org\/10.1128\/CMR.00133-20 (2021).","journal-title":"Clin. Microbiol. Rev."},{"key":"51737_CR2","unstructured":"COVID-19 cases | WHO COVID-19 dashboard. (2025). https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o&m49=955 (accessed 15 Mar 2025)."},{"issue":"4","key":"51737_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/hcs2.110","volume":"3","author":"B Shanmugaraj","year":"2024","unstructured":"Shanmugaraj, B. Emergence of SARS-CoV-2 variants KP.2 and KP.3 sparks concerns: What should we do? Health Care Sci. 3 (4), 211\u2013214. https:\/\/doi.org\/10.1002\/hcs2.110 (2024).","journal-title":"Health Care Sci."},{"issue":"10","key":"51737_CR4","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S1473-3099(24)00505-X","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku, Y., Uriu, K., Okumura, K., Ito, J. & Sato, K. Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant. Lancet Infect. Dis. 24 (10), e609. https:\/\/doi.org\/10.1016\/S1473-3099(24)00505-X (2024).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"51737_CR5","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","volume":"12","author":"D Lapuente","year":"2021","unstructured":"Lapuente, D. et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat. Commun. 12 (1), 6871. https:\/\/doi.org\/10.1038\/s41467-021-27063-4 (2021).","journal-title":"Nat. Commun."},{"issue":"11","key":"51737_CR6","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/vaccines10111946","volume":"10","author":"R Bezbaruah","year":"2022","unstructured":"Bezbaruah, R. et al. Nanoparticle-based delivery systems for vaccines. Vaccines (Basel). 10 (11), 1946. https:\/\/doi.org\/10.3390\/vaccines10111946 (2022).","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"51737_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/md18120605","volume":"18","author":"S Shim","year":"2020","unstructured":"Shim, S. & Yoo, H. S. The application of mucoadhesive chitosan nanoparticles in nasal drug delivery. Mar. Drugs. 18 (12), 605. https:\/\/doi.org\/10.3390\/md18120605 (2020).","journal-title":"Mar. Drugs"},{"issue":"4","key":"51737_CR8","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s12035-022-02756-z","volume":"59","author":"AM Howe","year":"2022","unstructured":"Howe, A. M., Burke, S., O\u2019Reilly, M. E., McGillicuddy, F. C. & Costello, D. A. Palmitic acid and oleic acid differently modulate TLR2-mediated inflammatory responses in microglia and macrophages. Mol. Neurobiol. 59 (4), 2348\u20132362. https:\/\/doi.org\/10.1007\/s12035-022-02756-z (2022).","journal-title":"Mol. Neurobiol."},{"issue":"17","key":"51737_CR9","doi-asserted-by":"publisher","first-page":"16971","DOI":"10.1074\/jbc.M312990200","volume":"279","author":"JY Lee","year":"2004","unstructured":"Lee, J. Y. et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1. J. Biol. Chem. 279 (17), 16971\u201316979. https:\/\/doi.org\/10.1074\/jbc.M312990200 (2004).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"51737_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/vaccines11020305","volume":"11","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. The development of surface-modified liposomes as an intranasal delivery system for group A Streptococcus vaccines. Vaccines (Basel). 11 (2), 305. https:\/\/doi.org\/10.3390\/vaccines11020305 (2023).","journal-title":"Vaccines (Basel)"},{"key":"51737_CR11","doi-asserted-by":"publisher","first-page":"117299","DOI":"10.1016\/j.carbpol.2020.117299","volume":"254","author":"N Ahmad","year":"2021","unstructured":"Ahmad, N., Wee, C. E., Wai, L. K., Zin, N. M. & Azmi, F. Biomimetic amphiphilic chitosan nanoparticles: Synthesis, characterization and antimicrobial activity. Carbohydr. Polym. 254, 117299. https:\/\/doi.org\/10.1016\/j.carbpol.2020.117299 (2021).","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"51737_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ajps.2022.04.002","volume":"17","author":"ASM Norpi","year":"2022","unstructured":"Norpi, A. S. M. et al. New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus. Asian J. Pharm. Sci. 17 (3), 435\u2013446. https:\/\/doi.org\/10.1016\/j.ajps.2022.04.002 (2022).","journal-title":"Asian J. Pharm. Sci."},{"issue":"1","key":"51737_CR13","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1038\/s41467-024-50020-w","volume":"15","author":"D Tang","year":"2024","unstructured":"Tang, D. et al. Nat. Commun. ;15(1), 6026. https:\/\/doi.org\/10.1038\/s41467-024-50020-w (2024).","journal-title":"Nat. Commun."},{"issue":"1","key":"51737_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jmr.1032","volume":"24","author":"K Hall","year":"2011","unstructured":"Hall, K., Lee, T. H. & Aguilar, M. I. The role of electrostatic interactions in the membrane binding of melittin. J. Mol. Recognit. 24 (1), 108\u2013118. https:\/\/doi.org\/10.1002\/jmr.1032 (2011).","journal-title":"J. Mol. Recognit."},{"key":"51737_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.scitotenv.2019.04.074","volume":"673","author":"H Zhang","year":"2019","unstructured":"Zhang, H., Wei, X., Liu, L., Zhang, Q. & Jiang, W. The role of positively charged sites in the interaction between model cell membranes and \u03b3-Fe2O3 NPs. Sci. Total Environ. 673, 414\u2013423. https:\/\/doi.org\/10.1016\/j.scitotenv.2019.04.074 (2019).","journal-title":"Sci. Total Environ."},{"key":"51737_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2020.10.012","volume":"29","author":"M Yuan","year":"2021","unstructured":"Yuan, M., Liu, H., Wu, N. C. & Wilson, I. A. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies. Biochem. Biophys. Res. Commun. 29, 538:192\u2013203. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.012 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"51737_CR17","doi-asserted-by":"publisher","first-page":"e00930","DOI":"10.1128\/mBio.00930-21","volume":"12","author":"BD Quinlan","year":"2020","unstructured":"Quinlan, B. D. et al. An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines. BioRxiv 12 (3), e00930\u2013e00921. https:\/\/doi.org\/10.1128\/mBio.00930-21 (2020).","journal-title":"BioRxiv"},{"issue":"1","key":"51737_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41541-021-00393-6","volume":"6","author":"H Kleanthous","year":"2021","unstructured":"Kleanthous, H. et al. Scientific rationale for developing potent RBD-based vaccines targeting COVID-19. NPJ Vaccines. 6 (1), 128. https:\/\/doi.org\/10.1038\/s41541-021-00393-6 (2021).","journal-title":"NPJ Vaccines"},{"issue":"1","key":"51737_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/S12951-023-01816-3","volume":"21","author":"PA Boley","year":"2023","unstructured":"Boley, P. A. et al. Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines. J. Nanobiotechnol. 21 (1), 60. https:\/\/doi.org\/10.1186\/S12951-023-01816-3 (2023).","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"51737_CR20","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/pathogens11091035","volume":"11","author":"WC Huang","year":"2022","unstructured":"Huang, W. C., Chiem, K., Martinez-Sobrido, L. & Lovell, J. F. Intranasal immunization with liposome-displayed receptor-binding domain induces mucosal immunity and protection against SARS-CoV-2. Pathogens 11 (9), 1035. https:\/\/doi.org\/10.3390\/pathogens11091035 (2022).","journal-title":"Pathogens"},{"key":"51737_CR21","doi-asserted-by":"publisher","first-page":"581469","DOI":"10.3389\/fimmu.2021.581469","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Risk factors for mortality of COVID-19 patient based on clinical course: A single center retrospective case-control study. Front. Immunol. 12, 581469. https:\/\/doi.org\/10.3389\/fimmu.2021.581469 (2021).","journal-title":"Front. Immunol."},{"key":"51737_CR22","doi-asserted-by":"publisher","first-page":"141227905","DOI":"10.3389\/fimmu.2021.581469","volume":"20","author":"Y Sun","year":"2023","unstructured":"Sun, Y., Dian, Y., Gao, Q. & Deng, G. Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8\u2009+\u2009T cell as a prognostic biomarker for patients with Nirmatrelvir. Front. Immunol. 20, 141227905. https:\/\/doi.org\/10.3389\/fimmu.2021.581469 (2023).","journal-title":"Front. Immunol."},{"issue":"11","key":"51737_CR23","doi-asserted-by":"publisher","first-page":"e24046","DOI":"10.1002\/jcla.24046","volume":"35","author":"F Ashrafi","year":"2021","unstructured":"Ashrafi, F., Nematollahi, P., Salmasi, M., Hedayat, A. & Amra, B. Association of lymphocyte subsets with mortality in severe COVID-19 pneumonia patients. J. Clin. Lab. Anal. 35 (11), e24046. https:\/\/doi.org\/10.1002\/jcla.24046 (2021).","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"51737_CR24","doi-asserted-by":"publisher","first-page":"e00930","DOI":"10.1038\/S41598-021-81749-9","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang, Z., Bogdan, P. & Nazarian, S. An in silico deep learning approach to multi-epitope vaccine design: A SARS-CoV-2 case study. Sci. Rep. 12 (3), e00930\u2013e00921. https:\/\/doi.org\/10.1038\/S41598-021-81749-9 (2021).","journal-title":"Sci. Rep."},{"issue":"22","key":"51737_CR25","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1016\/j.bmc.2014.09.042","volume":"22","author":"F Azmi","year":"2014","unstructured":"Azmi, F. et al. Self-adjuvanting vaccine against group A streptococcus: Application of fibrillized peptide and immunostimulatory lipid as adjuvant. Bioorg. Med. Chem. 22 (22), 6401\u20136408. https:\/\/doi.org\/10.1016\/j.bmc.2014.09.042 (2014).","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"51737_CR26","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.2217\/nnm-2016-0291","volume":"11","author":"N Marasini","year":"2016","unstructured":"Marasini, N. et al. Double adjuvanting strategy for peptide-based vaccines: Trimethyl chitosan nanoparticles for lipopeptide delivery. Nanomedicine 11 (24), 3223\u20133235. https:\/\/doi.org\/10.2217\/nnm-2016-0291 (2016).","journal-title":"Nanomedicine"},{"issue":"2","key":"51737_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/vaccines12020198","volume":"12","author":"P Koirala","year":"2024","unstructured":"Koirala, P. et al. Polymeric nanoparticles as oral and intranasal peptide vaccine delivery systems: The role of shape and conjugation. Vaccines (Basel). 12 (2), 198. https:\/\/doi.org\/10.3390\/vaccines12020198 (2024).","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"51737_CR28","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/vaccines9070768","volume":"9","author":"T Jearanaiwitayakul","year":"2021","unstructured":"Jearanaiwitayakul, T. et al. Intranasal administration of RBD nanoparticles confers induction of mucosal and systemic immunity against SARS-CoV-2. Vaccines (Basel). 9 (7), 768. https:\/\/doi.org\/10.3390\/vaccines9070768 (2021).","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"51737_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/pharmaceutics14010156","volume":"14","author":"NA Abdul Rahman","year":"2022","unstructured":"Abdul Rahman, N. A. et al. DENV-mimetic polymersome nanoparticles bearing multi-epitope lipopeptides antigen as the next-generation dengue vaccine. Pharmaceutics 14 (1), 156. https:\/\/doi.org\/10.3390\/pharmaceutics14010156 (2022).","journal-title":"Pharmaceutics"},{"issue":"3","key":"51737_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11515-009-0027-4","volume":"4","author":"L Huang","year":"2009","unstructured":"Huang, L. et al. Preparation, characterization, and antibacterial activity of oleic acid-grafted chitosan oligosaccharide nanoparticles. Front. Biol. China. 4 (3), 321\u2013327. https:\/\/doi.org\/10.1007\/s11515-009-0027-4 (2009).","journal-title":"Front. Biol. China"},{"issue":"9","key":"51737_CR31","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.biomaterials.2012.11.066","volume":"34","author":"B Koppolu","year":"2013","unstructured":"Koppolu, B. & Zaharoff, D. A. The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials 34 (9), 2359\u20132369. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.11.066 (2013).","journal-title":"Biomaterials"},{"key":"51737_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fonc.2018.00404","volume":"8","author":"J Jia","year":"2018","unstructured":"Jia, J. et al. Interactions between nanoparticles and dendritic cells: From the perspective of cancer immunotherapy. Front. Oncol. 8, 404. https:\/\/doi.org\/10.3389\/fonc.2018.00404 (2018).","journal-title":"Front. Oncol."},{"issue":"3","key":"51737_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"L Zhao","year":"2014","unstructured":"Zhao, L. et al. Nanoparticle vaccines. Vaccine 32 (3), 327\u2013337. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.069 (2014).","journal-title":"Vaccine"},{"issue":"12","key":"51737_CR34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41587-024-02486-8","volume":"42","author":"J Seo","year":"2024","unstructured":"Seo, J., Polster, J., Israelow, B., Corbett-Helaire, K. S. & Martinez, D. R. Challenges for developing broad-based mucosal vaccines for respiratory viruses. Nat. Biotechnol. 42 (12), 1765\u20131767. https:\/\/doi.org\/10.1038\/s41587-024-02486-8 (2024).","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"51737_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","volume":"10","author":"X Zhou","year":"2025","unstructured":"Zhou, X. et al. Mucosal immune response in biology, disease prevention and treatment. Signal. Transduct. Target. Ther. 10 (1), 7. https:\/\/doi.org\/10.1038\/s41392-024-02043-4 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"51737_CR36","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1016\/j.jvacx.2024.100443","volume":"16","author":"IA Safitri","year":"2024","unstructured":"Safitri, I. A. et al. Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in Escherichia coli. Vaccine X. 16, 10043. https:\/\/doi.org\/10.1016\/j.jvacx.2024.100443 (2024).","journal-title":"Vaccine X"},{"key":"51737_CR37","doi-asserted-by":"publisher","first-page":"854630","DOI":"10.3389\/fmicb.2022.854630","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. A bacterially expressed SARS-CoV-2 receptor binding domain fused with cross-reacting material 197 A-domain elicits high level of neutralizing antibodies in mice. Front. Microbiol. 13, 854630. https:\/\/doi.org\/10.3389\/fmicb.2022.854630 (2022).","journal-title":"Front. Microbiol."},{"issue":"3","key":"51737_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/vaccines3030579","volume":"3","author":"T Stratmann","year":"2015","unstructured":"Stratmann, T. Cholera toxin subunit b as adjuvant\u2014an accelerator in protective immunity and a break in autoimmunity. Vaccines (Basel). 3 (3), 579\u2013596. https:\/\/doi.org\/10.3390\/vaccines3030579 (2015).","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"51737_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imm.13526","volume":"167","author":"VA Correa","year":"2022","unstructured":"Correa, V. A., Portilho, A. I. & De Gaspari, E. Vaccines, adjuvants and key factors for mucosal immune response. Immunology 167 (2), 124\u2013138. https:\/\/doi.org\/10.1111\/imm.13526 (2022).","journal-title":"Immunology"},{"issue":"1","key":"51737_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/infdis\/171.1.198","volume":"171","author":"KA Brokstad","year":"1995","unstructured":"Brokstad, K. A., Cox, R. J., Olofsson, J., Jonsson, R. & Haaheim, L. R. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 171 (1), 198\u2013203. https:\/\/doi.org\/10.1093\/infdis\/171.1.198 (1995).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"51737_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/S41541-024-00912-1","volume":"9","author":"C Bissett","year":"2024","unstructured":"Bissett, C. et al. Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine. NPJ Vaccines. 9 (1), 118. https:\/\/doi.org\/10.1038\/S41541-024-00912-1 (2024).","journal-title":"NPJ Vaccines"},{"issue":"1","key":"51737_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/S12951-023-02229-Y","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. A novel prime and pull strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge. J. Nanobiotechnol. 21 (1), 479. https:\/\/doi.org\/10.1186\/S12951-023-02229-Y (2023).","journal-title":"J. Nanobiotechnol."},{"key":"51737_CR43","doi-asserted-by":"publisher","first-page":"104248","DOI":"10.1016\/j.ebiom.2022.104248","volume":"84","author":"D Christensen","year":"2022","unstructured":"Christensen, D. et al. Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy. EBioMedicine 84, 104248. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104248 (2022).","journal-title":"EBioMedicine"},{"issue":"9","key":"51737_CR44","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1101\/2022.04.06.487394","volume":"10","author":"MM Shamseldin","year":"2023","unstructured":"Shamseldin, M. M. et al. Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal 1 immunity and prevents SARS CoV-2 infection and pathology. J. Immunol. 10 (9), 1257\u20131271. https:\/\/doi.org\/10.1101\/2022.04.06.487394 (2023).","journal-title":"J. Immunol."},{"issue":"8","key":"51737_CR45","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/vaccines11081333","volume":"11","author":"SC Gaglio","year":"2023","unstructured":"Gaglio, S. C., Perduca, M., Zipeto, D. & Bardi, G. Efficiency of chitosan nanocarriers in vaccinology for mucosal immunization. Vaccines (Basel). 11 (8), 1333. https:\/\/doi.org\/10.3390\/vaccines11081333 (2023).","journal-title":"Vaccines (Basel)"},{"key":"51737_CR46","doi-asserted-by":"publisher","first-page":"125168","DOI":"10.1016\/j.ijpharm.2025.125168","volume":"670","author":"R Chen","year":"2025","unstructured":"Chen, R. et al. Int. J. Pharm. 670, 125168. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125168 (2025).","journal-title":"Int. J. Pharm."},{"key":"51737_CR47","doi-asserted-by":"publisher","first-page":"105185","DOI":"10.1016\/j.ebiom.2024.105185","volume":"105","author":"S Slamanig","year":"2024","unstructured":"Slamanig, S. et al. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. EBioMedicine 105, 105185. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105185 (2024).","journal-title":"EBioMedicine"},{"issue":"3","key":"51737_CR48","doi-asserted-by":"publisher","first-page":"taab191","DOI":"10.1093\/jtm\/taab191","volume":"29","author":"B Sapkota","year":"2022","unstructured":"Sapkota, B. et al. Heterologous prime-boost strategies for COVID-19 vaccines. J. Travel Med. 29 (3), taab191. https:\/\/doi.org\/10.1093\/jtm\/taab191 (2022).","journal-title":"J. Travel Med."},{"issue":"8","key":"51737_CR49","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.chom.2023.07.004","volume":"31","author":"YF Hu","year":"2023","unstructured":"Hu, Y. F. et al. Rational design of a booster vaccine against COVID-19 based on antigenic distance. Cell. Host Microbe. 31 (8), 1301\u20131316e8. https:\/\/doi.org\/10.1016\/j.chom.2023.07.004 (2023).","journal-title":"Cell. Host Microbe"},{"issue":"2","key":"51737_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cellimm.2015.01.006","volume":"293","author":"L Zhao","year":"2015","unstructured":"Zhao, L. et al. Essential role of TNF-alpha in development of spleen fibroblastic reticular cells. Cell. Immunol. 293 (2), 130\u2013136. https:\/\/doi.org\/10.1016\/j.cellimm.2015.01.006 (2015).","journal-title":"Cell. Immunol."},{"issue":"2","key":"51737_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","volume":"5","author":"L Guglani","year":"2010","unstructured":"Guglani, L. & Khader, S. A. Th17 cytokines in mucosal immunity and inflammation. Curr. Opin. HIV AIDS. 5 (2), 120\u2013127. https:\/\/doi.org\/10.1097\/COH.0b013e328335c2f6 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"12","key":"51737_CR52","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1016\/j.ymthe.2024.10.016","volume":"32","author":"G Laghlali","year":"2024","unstructured":"Laghlali, G. et al. Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime\/intranasal protein boost vaccination with a combination adjuvant. Mol. Ther. 32 (12), 4448\u20134466. https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.016 (2024).","journal-title":"Mol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51737-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51737-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51737-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:36:51Z","timestamp":1783467411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51737-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51737"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51737-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics declarations"}},{"value":"All animal experimentation protocols received approval from the University Kebangsaan Malaysia Animal Ethics Committee guideline and were carried out in compliance with the Guidelines for the Care and Use of Laboratory Animals established by the institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21102"}}